UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Dunhill Financial LLC

Dunhill Financial LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 18.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 418 shares of the healthcare conglomerate’s stock after acquiring an additional 65 shares during the period. Dunhill Financial LLC’s holdings in UnitedHealth Group were worth $244,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also modified their holdings of the company. RFG Advisory LLC grew its stake in shares of UnitedHealth Group by 5.0% during the second quarter. RFG Advisory LLC now owns 4,888 shares of the healthcare conglomerate’s stock worth $2,489,000 after purchasing an additional 233 shares in the last quarter. Aspire Private Capital LLC grew its stake in shares of UnitedHealth Group by 2.1% during the second quarter. Aspire Private Capital LLC now owns 1,851 shares of the healthcare conglomerate’s stock worth $943,000 after purchasing an additional 38 shares in the last quarter. Northeast Financial Group Inc. grew its stake in shares of UnitedHealth Group by 3.4% during the second quarter. Northeast Financial Group Inc. now owns 4,446 shares of the healthcare conglomerate’s stock worth $2,264,000 after purchasing an additional 146 shares in the last quarter. Financial Partners Group LLC grew its stake in shares of UnitedHealth Group by 1.8% during the second quarter. Financial Partners Group LLC now owns 7,988 shares of the healthcare conglomerate’s stock worth $4,068,000 after purchasing an additional 143 shares in the last quarter. Finally, D.B. Root & Company LLC grew its stake in shares of UnitedHealth Group by 26.3% during the second quarter. D.B. Root & Company LLC now owns 960 shares of the healthcare conglomerate’s stock worth $489,000 after purchasing an additional 200 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 5.1 %

NYSE UNH opened at $549.62 on Friday. The stock has a market capitalization of $505.81 billion, a P/E ratio of 35.81, a P/E/G ratio of 1.79 and a beta of 0.58. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The firm has a 50-day moving average price of $586.84 and a 200 day moving average price of $558.81. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same period in the prior year, the business posted $6.56 earnings per share. The firm’s revenue for the quarter was up 9.2% compared to the same quarter last year. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.63 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.53%. UnitedHealth Group’s payout ratio is currently 54.72%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research reports. Cantor Fitzgerald boosted their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Morgan Stanley reduced their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Hsbc Global Res cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Royal Bank of Canada reduced their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Finally, Stephens boosted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday. Four equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $626.84.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.